Post-COVID-19-pandemic changes and clinical characteristics of invasive group a streptococcal infections from 2015 to 2023.

Purpose: Since winter 2022, invasive GAS (iGAS) infections have re-emerged in Europe, causing severe diseases in children and adults. We aimed to examine whether this reported post-pandemic increase was associated with an increased disease severity and/or a shift in clinical disease phenotypes. Meth...

Descripción completa

Detalles Bibliográficos
Publicado en:Infection Vol. 53; no. 3; pp. 991 - 1001
Autores principales: Tomidis Chatzimanouil, Markos K., Rößler, Susann, Nurjadi, Dennis, Iakovidis, Isidoros, Berner, Reinhard, Toepfner, Nicole, Bornstein, the Dresden G. A. S. Study Group: Stefan Richard, Aschoff, Roland, Bornhäuser, Martin, Güldner, Andreas, Gunzer, Florian, Herold, Johannes, Schultz, Jurek, Wimberger, Pauline, Zahnert, Thomas
Formato: research tables/charts Journal Article
Publicado: Springer Nature Jun2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185686809&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 185686809
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03008126
        NXO
      jtl: Infection
      issn: 03008126
      maglogo: N
    pubinfo:
      dt: Jun2025
      vid: 53
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        185686809
        180316235
        185686809
        185686809
        10.1007/s15010-024-02413-8
        185686809
      ppf: 991
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Post-COVID-19-pandemic changes and clinical characteristics of invasive group a streptococcal infections from 2015 to 2023.
      aug:
        au:
          Tomidis Chatzimanouil, Markos K.
          Rößler, Susann
          Nurjadi, Dennis
          Iakovidis, Isidoros
          Berner, Reinhard
          Toepfner, Nicole
          Bornstein, the Dresden G. A. S. Study Group: Stefan Richard
          Aschoff, Roland
          Bornhäuser, Martin
          Güldner, Andreas
          Gunzer, Florian
          Herold, Johannes
          Schultz, Jurek
          Wimberger, Pauline
          Zahnert, Thomas
        affil: https://ror.org/042aqky30 Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Fetscherstraße 74, 01307, Dresden, Germany
      sug:
        subj:
          COVID-19 Pandemic Adverse Effects
          Streptococcal Infections Symptoms
          Streptococcal Infections Trends
          Streptococcal Infections Drug Therapy
          Severity of Illness
          Clindamycin Therapeutic Use
          Immunoglobulins, Intravenous Therapeutic Use
          Mortality Prevention and Control
          Sepsis Mortality
          Toxic Shock Syndrome Mortality
          Human
          Tertiary Health Care
          Germany
          Phenotype
          Length of Stay
          Treatment Duration
          Child
          Adult
          Intensive Care Units, Pediatric
          Catecholamines Therapeutic Use
          Respiration, Artificial
          Descriptive Statistics
          Retrospective Design
          Record Review
          Child: 6-12 years
          Adult: 19-44 years
      ab: Purpose: Since winter 2022, invasive GAS (iGAS) infections have re-emerged in Europe, causing severe diseases in children and adults. We aimed to examine whether this reported post-pandemic increase was associated with an increased disease severity and/or a shift in clinical disease phenotypes. Methods: We performed detailed clinical phenotyping of patients hospitalized with iGAS infections at a 1410-bed tertiary German Medical Center from 01/2015 to 09/2023. Results: One hundred seventy-eight patients were included: 50 children (28.1%) and 128 adults (71.9%). IGAS infections of Q1/2023 exceeded the pre-pandemic average by 551% (1200% for children). The mean age of affected patients shifted significantly post-pandemically (49.5 ± 26.5 to 32.4 ± 28.2 years of age, p < 0.05), mainly due to the higher percentage of children affected with iGAS infections (15.2% pre-pandemic, 44.2% post-pandemic). CFR was significantly lower for children (2%) compared to adults (11.7%) (p < 0.05) and decreased from 13% to 6.5% post-pandemically (p = 0.148). Duration of antibiotic therapy (13.5 (10 to 21) to 10 (9 to 14) days), length of hospital (10 (4 to 25) to 7 (5 to 15) days), and ICU stay (7.0 (2.5 to 18.0) to 5.0 (3.0 to 8.5) days) were shorter post-pandemically. Despite the higher post-pandemic percentage of affected children, PICU admissions (57% before to 32% after), use of catecholamines (28.6% to 11.8%), invasive ventilation (35.7% to 17.6%) and CFR (7% to 0%) were all lower after the pandemic. Conclusion: Children were at higher risk for iGAS infections post-pandemically. The surge of post-pandemic iGAS infections was not accompanied by increased iGAS-associated morbidity and mortality.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N